The range of medical, psychological, and social services designed to help individuals reduce or stop substance use and manage substance use disorders. Treatment may include assessment, counselling and behavioural therapies, medication-assisted treatment, withdrawal management, and support for co-occurring mental or physical health conditions. Effective treatment is typically person-centred and evidence-informed, and may be provided in outpatient, community, or residential settings. Treatment aims to improve health and functioning, reduce substance-related harms, and support individuals in moving toward recovery and long-term wellbeing.
Treatment
Anxiety and Alcohol Use: What Clinicians Need to Know
Presented by Associate Professor Lexine Stapinski (the Matilda Centre) this webinar will lead to: 1. An understanding of typical patterns and issues relevant to the management of anxiety and alcohol use disorder comorbidity; 2. Introduction...
UNODC Keeps Supporting Quality Drug Treatment Service via Continuous Capacity Building
UNODC Regional Office for Central Asia supported regional training of trainers (ToT) on Course 11 “Enhancing Motivational Interviewing Skills”. This course is part of the Advanced Level of the Universal Treatment Curriculum for Substance...
Research for practice: Training the competent practitioner
Join hosts Drs William Miller, Goodman Sibeko and team, for a discourse on Motivational Interviewing research in Africa. How successful have we been in training competent practitioners and what have we learned in the process?
This Webinar is the third of a series focussed on Motivational Interviewing in Africa.
Supporting Families in Recovery – Global Approaches in the Context of COVID-19
Supporting Families in Recovery: Global Approaches in the Context of COVID-19
WHO Quitting Toolkit
With professional support and quitting services, tobacco users double their chances of quitting successfully. This WHO toolkit is aimed at tobacco users and is designed to provide information, reasons to quit and resources in an easily accessible format.
Toolkit for delivering the 5A’s and 5R’s brief tobacco interventions in primary care
This toolkit was developed based on WHO Capacity Building Training Package 4 entitled “Strengthening health systems for treating tobacco dependence in primary care”. Its target audience are primary care providers.
Fenacetina: Un Adulterante Tóxico Encontrado en Drogas Callejeras Ilegales
Las personas encargadas del tratamiento por abuso de sustancias, quienes ejercen la medicina clínica, los/las extensionistas, las clínicas de salud pública, entre otros, deben conocer la información que se detalla a continuación. La...
Mindfulness-Oriented Recovery Enhancement Remediates Hedonic Dysregulation in Opioid Users: Neural and Affective Evidence of Target Engagement
Abstract Addiction neuroscience models posit that recurrent drug use increases reactivity to drug-related cues and blunts responsiveness to natural rewards, propelling a cycle of hedonic dysregulation that drives addictive behavior. Here...
Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine: A Randomized Clinical Trial
Abstract Importance: Patient-reported outcomes in the treatment of opioid dependence may differ between subcutaneously administered depot buprenorphine and daily sublingual buprenorphine. Objective: To compare patient satisfaction between...
An Interprofessional Approach to Providing Medication Treatment for Transitional Aged Youth with Opioid Use Disorder
Register now: https://register.gotowebinar.com/register/1407462158412714251
Wednesday, May 19, 2021, 2:00 PM - 3:00 PM ET (Washington, DC time)